CRNX
CRNX
NASDAQ · Pharmaceuticals

Crinetics Pharmaceuticals In

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$84.95
+0.11 (+0.13%)
As of Sep 22, 9:53 PM ET ·
Analyst Consensus
Hold
20
Analysts
High
Coverage
Buy 6 30%
Hold 14 70%
Sell 0 0%
Price Target
Analyst Price Target -41.8% upside
Low Target $38.77
Average Target $49.40
High Target $74.88
Current Price $84.95
Current
$84.95
Target
$49.40
$38.77 $49.40 avg $74.88
Scenario Analysis
Bear Case
$38.77
-54.4%
Low target
Base Case
$49.40
-41.8%
Avg target
Bull Case
$74.88
+-11.9%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$85.01
-0.1% from high
52-Week Low
$32.30
+163.0% from low
50-Day SMA
$49.40
+72.0% vs SMA
200-Day SMA
$38.81
+118.9% vs SMA
RSI (14)
27.9
Oversold
Target vs 52W High
$49.40
-41.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +13.7%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.3%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +5.5%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +21.4%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +180.3%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +188.0%